171 related articles for article (PubMed ID: 3096583)
1. The physiology and pathophysiology of the factor VIII complex.
Hamer RJ; Houdijk WP; Sixma JJ
Crit Rev Oncol Hematol; 1986; 6(1):19-54. PubMed ID: 3096583
[TBL] [Abstract][Full Text] [Related]
2. The factor VIII/von Willebrand factor complex: basic and clinical issues.
Federici AB
Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
[TBL] [Abstract][Full Text] [Related]
3. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.
Terraube V; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jan; 16(1):3-13. PubMed ID: 19473409
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
7. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
Kiouptsi K; Reinhardt C
Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
9. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
Kao KJ; Pizzo SV; McKee PA
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
Zimmerman TS; Voss R; Edgington TS
J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
[TBL] [Abstract][Full Text] [Related]
11. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
12. Association between bleeding time and platelet adherence to artery subendothelium.
Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
14. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor in the vessel wall mediates platelet adherence.
Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
[TBL] [Abstract][Full Text] [Related]
17. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
Sakariassen KS; Nieuwenhuis HK; Sixma JJ
Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
[TBL] [Abstract][Full Text] [Related]
19. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.
Mazurier C; Dieval J; Jorieux S; Delobel J; Goudemand M
Blood; 1990 Jan; 75(1):20-6. PubMed ID: 2104761
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.
Kessler CM; Friedman K; Schwartz BA; Gill JC; Powell JS;
Thromb Haemost; 2011 Aug; 106(2):279-88. PubMed ID: 21725579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]